Sequenom Inc (NASDAQ:SQNM)

3.90
Delayed Data
As of Mar 27
 +0.08 / +2.09%
Today’s Change
2.25
Today|||52-Week Range
4.19
+5.41%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$450.6M

Company Description

SEQUENOM, Inc. is a life sciences company providing innovative genomic and genetic analysis solutions for the clinical research and molecular diagnostic markets. The company operates its business under two segments: Sequenom Laboratories and Sequenom Bioscience. The Sequenom Laboratories segment runs through its subsidiary, Sequenom Center for Molecular Medicine, LLC, which performs molecular diagnostic testing services utilizing its laboratory-developed tests which are currently focused on noninvasive prenatal and women's health related diagnostics and ophthalmology-related diagnostics and plans to develop or acquire additional diagnostic tests in those and other fields, including autoimmunity, neurology and oncology. The Sequenom Bioscience segment provides research use technologies and tools that translate the results of genomic science into solutions for biomedical research, translational research, oncology, agricultural genomics, clinical diagnostics, molecular medicine applications, and other areas of research, including agricultural and livestock. SEQUENOM was founded by Hubert Koester and Charles R. Cantor in 1994 and is headquartered in San Diego, CA.

Contact Information

SEQUENOM, Inc.
3595 John Hopkins Court
San Diego California 92121-1331
P:(858) 202-9000
Investor Relations:
(858) 202-9028

Employees

Shareholders

Other institutional37.03%
Mutual fund holders21.14%
Individual stakeholders17.84%

Top Executives

William J. WelchPresident, CEO, Chief Operating Officer & Director
Carolyn D. BeaverVP, Chief Financial & Accounting Officer
Dirk van den BoomChief Scientific and Strategy Officer
Charles R. CantorChief Scientific Officer
Allan T. BombardChief Medical Officer

To view my watchlist

Not a member yet?

Sign up now for a free account